Company Introduction
Zhejiang Changming Pharmaceutical Co., Ltd, established in 2006, is the subsidiary of Zhejiang Shengda Group. Changming specializes in research, development, production and marketing of cardiovascular and other therapeutic drug related APls and intermediates. Changming is one of leading suppliers of pharmaceutical grade ACE inhibitor APIs and intermediates. The leading products include: Enalapril, Ramipril, Lisinopril, Benfotiamine, Doxofylline,etc.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,